Automated description from the Alliance of Genome Resources (Release 7.4.0)
Enables cysteine-type endopeptidase inhibitor activity involved in apoptotic process. Acts upstream of or within T cell differentiation; T cell receptor signaling pathway; and negative regulation of cysteine-type endopeptidase activity involved in apoptotic process. Predicted to be located in cytoplasm. Predicted to be active in mitochondrial outer membrane. Is expressed in several structures, including adipose tissue; craniocervical region bone; hemolymphoid system; liver; and respiratory system. Orthologous to human BCL2A1 (BCL2 related protein A1).
This site uses cookies.
Some cookies are essential for site operations and others help us analyze use and utility of our web site.
Please refer to our
privacy policy
for more information.